Adding Bowel Ultrasound to Care for Crohn's Disease and Ulcerative Colitis
Tests whether bowel ultrasound changes treatment in adults with Crohn's disease or ulcerative colitis.
Plain-language title generated from the registry record
Registry title: Intestinal Ultrasound Guided Management in Inflammatory Bowel Disease
Key facts
- Where
- Bangkok, ThailandSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have had Crohn's disease or ulcerative colitis for more than 2 months and are having a colonoscopy to check their disease.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Inflammatory bowel disease (Crohn's disease or ulcerative colitis) diagnosed more than 2 months ago, having an endoscopy at enrollment to assess how severe it is
- Earlier treatment
- Biologic failure is an exclusion; no other prior treatment is asked for
Main reasons for not taking part
- Pregnancy
- Unstable underlying medical conditions
- Disease limited to the distal rectum (within 10 cm (3.9 in) of the anal verge) or perianal disease only
- Biologic failure
Read by machine on 9 November 2026.
Where in Thailand
- Faculty of Medicine Siriraj Hospital, Mahidol UniversityBangkok, ThailandContact: Thanaboon Chaemsupaphan, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Mahidol University
- Trial code
- NCT07775352
- Record updated
- 14 October 2026
- Original description
This randomized controlled trial evaluates whether adding point-of-care intestinal ultrasound (IUS) to standard of care changes clinical management in patients with inflammatory bowel disease (IBD). Adult patients with Crohn's disease or ulcerative colitis undergoing colonoscopy for disease assessment are randomized 1:1 to standard of care plus IUS at every visit, or standard of care alone, and followed for 48 weeks. The primary outcome is the proportion of patients with a change in treatment.Read full original descriptionShow less
A Randomized Controlled Trial Comparing Standard of Care With and Without Intestinal Ultrasound Guidance in Patients With Inflammatory Bowel Diseases
This randomized controlled trial evaluates whether adding point-of-care intestinal ultrasound (IUS) to standard of care changes clinical management in patients with inflammatory bowel disease (IBD). Adult patients with Crohn's disease or ulcerative colitis undergoing colonoscopy for disease assessment are randomized 1:1 to standard of care plus IUS at every visit, or standard of care alone, and followed for 48 weeks. The primary outcome is the proportion of patients with a change in treatment.
Inclusion: Diagnosis of inflammatory bowel disease for more than 2 months; Age 18 years or older; Undergoing endoscopy at enrollment for assessment of disease severity.
Exclusion: Unstable underlying medical conditions; Inflammatory bowel disease limited to the distal rectum (within 10 cm of the anal verge) or perianal disease only; Biologic failure; Pregnancy.